Live stream preview

Watch this video and more on PCCA Play

Watch this video and more on PCCA Play

Subscribe

Already subscribed? Sign in

Utilization of LDN in the Pediatric Population

LDN • 31m

Utilization of LDN in the Pediatric Population

31 min
Handout: https://bit.ly/4eG3KA7

During this session, Trcia Heitman, PharmD, will discuss why low dose naltrexone (LDN) is a good therapeutic option in pediatric autoimmune disease, the literature available supporting the use of LDN in children, the possible options for the use of LDN in children, and understand the marketing challenges and addrfessing fear that parents of practitioners may have regarding compounded LDN treatment.

Up Next in LDN

  • COVID-19 and Post-COVID-19 Syndrome
    57:02
    COVID-19 and Post-COVID-19 Syndrome

    COVID-19 and Post-COVID-19 Syndrome

    57 min
    Handout: https://bit.ly/49AiLCE

    During this session, Pamela W. Smith, MD, MPH, MS will discuss precision medicine adjunct therapies for COVID-19 and explore precision medicine adjuct treatments for Post COVID-19 Syndrome and Post COVID-19 Vaccine Syndrome.

  • Autoimmune Diseases and the Use of LD...
    45:11
    Autoimmune Diseases and the Use of LD...

    Autoimmune Diseases and the Use of LD...

    45 Minutes
    Handout: https://bit.ly/3AecPly

    During this session, Pamela W. Smith, MD, MPH, MS will discuss autoimmune diseases and the use of LDN.

  • Autoimmune Diseases and the Use of LDN
    1:14:38
    Autoimmune Diseases and the Use of LDN

    Autoimmune Diseases and the Use of LDN

    1 Hour 14 Minutes
    Handout: https://bit.ly/3AecPly

    During this session, Pamela W. Smith, MD, MPH, MS will discuss autoimmune diseases and the use of LDN.

×